Please login to the form below

Not currently logged in
Email:
Password:

AntiCoagulation Europe

This page shows the latest AntiCoagulation Europe news and features for those working in and with pharma, biotech and healthcare.

Hey You! campaign targets over 60s at high risk of stroke

Hey You! campaign targets over 60s at high risk of stroke

Eve Knight, co-founder and chief executive of AntiCoagulation Europe - one of the 'Hey You!' campaign partners - said: “ AF is the most common abnormal heart rhythm in the UK, significantly increasingly ... It's important we're supporting AF patients

Latest news

  • Quality in Care anticoagulation programme open for entry Quality in Care anticoagulation programme open for entry

    UK. The programme is supported in 2015 by Bayer Healthcare, AntiCoagulation Europe (ACE), Stroke Association, Arrhythmia Alliance, Atrial Fibrillation Association and Lifeblood: The Thrombosis Charity. ... The deadline for entries is June 11 and

  • Good practice in blood clot care recognised at awards Good practice in blood clot care recognised at awards

    He is currently an executive of the Atrial Fibrillation Association, STARS (the Syncope Trust), Arrhythmia Alliance, Anticoagulation Europe and is on the expert advisory panel for the Stroke Association. ... QiC Anticoagulation is supported by Bayer

  • Bayer’s Xarelto cleared in Europe for pulmonary embolism and DVT prevention Bayer’s Xarelto cleared in Europe for pulmonary embolism and DVT prevention

    The latest approval gives Xarelto (rivaroxaban) an edge over its rival anticoagulant, Boehringer's Pradaxa (dabigatran etexilate), which is only available in Europe for the latter two prevention indications. ... Eve Knight, co-founder and CEO of the

  • Boehringer rewarded for digital communications excellence

    The company, whose key brand in the area is Pradaxa (dabigatran), worked with more than 40 patient and professional organisations during the campaign, including AntiCoagulation Europe, the Arrhythmia Alliance, the Atrial ... Fibrillation Association, the

  • Boehringer rewarded for digital communications excellence

    The company, whose key brand in the area is Pradaxa (dabigatran), worked with more than 40 patient and professional organisations during the campaign, including AntiCoagulation Europe, the Arrhythmia Alliance, the Atrial ... Fibrillation Association, the

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics